1. A double‐blind, randomized, multicenter phase 3 study of palonosetron vs granisetron combined with dexamethasone and fosaprepitant to prevent chemotherapy‐induced nausea and vomiting in patients with breast cancer receiving anthracycline and cyclophosphamide. (13th March 2020) Authors: Matsumoto, Koji; Takahashi, Masato; Sato, Kazuhiko; Osaki, Akihiko; Takano, Toshimi; Naito, Yoichi; Matsuura, Kazuo; Aogi, Kenjiro; Fujiwara, Kimiko; Tamura, Kenji; Baba, Motoi; Tokunaga, Shinya; Hirano, Gen; Imoto, Shigeru; Miyazaki, Chieko; Yanagihara, Kazuhiro; Imamura, Chiyo K.; Chiba, Yasuta... Journal: Cancer medicine Issue: Volume 9:Number 10(2020) Page Start: 3319 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A phase I/II trial of olaparib tablet in combination with eribulin in Japanese patients with advanced or metastatic triple-negative breast cancer previously treated with anthracyclines and taxanes. (March 2019) Authors: Yonemori, Kan; Shimomura, Akihiko; Yasojima, Hiroyuki; Masuda, Norikazu; Aogi, Kenjiro; Takahashi, Masato; Naito, Yoichi; Shimizu, Satoru; Nakamura, Rikiya; Hashimoto, Jun; Yamamoto, Harukaze; Hirakawa, Akihiro; Michimae, Hirofumi; Hamada, Akinobu; Yoshida, Teruhiko; Sukigara, Tamie; Tamura, Kenj... Journal: European journal of cancer Issue: Volume 109(2019) Page Start: 84 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. A randomized phase II trial of trastuzumab plus capecitabine versus lapatinib plus capecitabine in patients with HER2-positive metastatic breast cancer previously treated with trastuzumab and taxanes: WJOG6110B/ELTOP. (August 2018) Authors: Takano, Toshimi; Tsurutani, Junji; Takahashi, Masato; Yamanaka, Takeharu; Sakai, Kazuko; Ito, Yoshinori; Fukuoka, Junya; Kimura, Hideharu; Kawabata, Hidetaka; Tamura, Kenji; Matsumoto, Koji; Aogi, Kenjiro; Sato, Kazuhiko; Nishio, Kazuto; Nakagawa, Kazuhiko; Saeki, Toshiaki Journal: Breast Issue: Volume 40(2018) Page Start: 67 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Adjuvant S-1 plus endocrine therapy for oestrogen receptor-positive, HER2-negative, primary breast cancer: a multicentre, open-label, randomised, controlled, phase 3 trial. Issue 1 (January 2021) Authors: Toi, Masakazu; Imoto, Shigeru; Ishida, Takanori; Ito, Yoshinori; Iwata, Hiroji; Masuda, Norikazu; Mukai, Hirofumi; Saji, Shigehira; Shimizu, Akira; Ikeda, Takafumi; Haga, Hironori; Saeki, Toshiaki; Aogi, Kenjiro; Sugie, Tomoharu; Ueno, Takayuki; Kinoshita, Takayuki; Kai, Yuichiro; Kitada, Masahir... Journal: Lancet oncology Issue: Volume 22:Issue 1(2021) Page Start: 74 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Body mass index and survival after diagnosis of invasive breast cancer: a study based on the Japanese National Clinical Database—Breast Cancer Registry. (29th February 2016) Authors: Kawai, Masaaki; Tomotaki, Ai; Miyata, Hiroaki; Iwamoto, Takayuki; Niikura, Naoki; Anan, Keisei; Hayashi, Naoki; Aogi, Kenjiro; Ishida, Takanori; Masuoka, Hideji; Iijima, Kotaro; Masuda, Shinobu; Tsugawa, Koichiro; Kinoshita, Takayuki; Nakamura, Seigo; Tokuda, Yutaka Journal: Cancer medicine Issue: Volume 5:Number 6(2016:Jun.) Page Start: 1328 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Changes in Recurrence Score by neoadjuvant endocrine therapy of breast cancer and their prognostic implication. Issue 1 (27th February 2019) Authors: Ueno, Takayuki; Saji, Shigehira; Masuda, Norikazu; Iwata, Hiroji; Kuroi, Katsumasa; Sato, Nobuaki; Takei, Hiroyuki; Yamamoto, Yutaka; Ohno, Shinji; Yamashita, Hiroko; Hisamatsu, Kazufumi; Aogi, Kenjiro; Sasano, Hironobu; Toi, Masakazu Journal: ESMO open Issue: Volume 4:Issue 1(2019) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Clinical significance of the expression of autophagy-associated marker, beclin 1, in breast cancer patients who received neoadjuvant endocrine therapy. Issue 1 (December 2016) Authors: Ueno, Takayuki; Saji, Shigehira; Sugimoto, Masahiro; Masuda, Norikazu; Kuroi, Katsumasa; Sato, Nobuaki; Takei, Hiroyuki; Yamamoto, Yutaka; Ohno, Shinji; Yamashita, Hiroko; Hisamatsu, Kazufumi; Aogi, Kenjiro; Iwata, Hiroji; Imoto, Shigeru; Sasano, Hironobu; Toi, Masakazu Journal: BMC cancer Issue: Volume 16:Issue 1(2016) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Comparison of an AC‐taxane versus AC‐free regimen and paclitaxel versus docetaxel in patients with lymph node‐positive breast cancer: Final results of the National Surgical Adjuvant Study of Breast Cancer 02 trial, a randomized comparative phase 3 study. Issue 5 (12th January 2017) Authors: Watanabe, Toru; Kuranami, Masaru; Inoue, Kenichi; Masuda, Norikazu; Aogi, Kenjiro; Ohno, Shinji; Iwata, Hiroji; Mukai, Hirofumi; Uemura, Yukari; Ohashi, Yasuo Journal: Cancer Issue: Volume 123:Issue 5(2017) Page Start: 759 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Extended adjuvant intermittent letrozole versus continuous letrozole in postmenopausal women with breast cancer (SOLE): a multicentre, open-label, randomised, phase 3 trial. Issue 1 (January 2018) Authors: Colleoni, Marco; Luo, Weixiu; Karlsson, Per; Chirgwin, Jacquie; Aebi, Stefan; Jerusalem, Guy; Neven, Patrick; Hitre, Erika; Graas, Marie-Pascale; Simoncini, Edda; Kamby, Claus; Thompson, Alastair; Loibl, Sibylle; Gavilá, Joaquín; Kuroi, Katsumasa; Marth, Christian; Müller, Bettina; O'Reilly, Seam... Journal: Lancet oncology Issue: Volume 19:Issue 1(2018) Page Start: 127 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Factors associated with overall survival after recurrence in patients with ER-positive/HER2-negative postmenopausal breast cancer: an ad hoc analysis of the JBCRG-C06 Safari study. (16th March 2022) Authors: Kawaguchi, Hidetoshi; Yamamoto, Yutaka; Saji, Shigehira; Masuda, Norikazu; Nakayama, Takahiro; Aogi, Kenjiro; Anan, Keisei; Ito, Yoshinori; Ohtani, Shoichiro; Sato, Nobuaki; Takano, Toshimi; Tokunaga, Eriko; Nakamura, Seigo; Hasegawa, Yoshie; Hattori, Masaya; Fujisawa, Tomomi; Morita, Satoshi; Ya... Journal: Japanese journal of clinical oncology Issue: Volume 52:Number 6(2022) Page Start: 545 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗